Product logins

Find logins to all Clarivate products below.


John Lebbos

Partner, Commercial Strategy Consulting

John Lebbos, MD is a Partner in Clarivate’s Commercial Strategy Consulting team.​​​

He is currently a practice leader in Product and Market Opportunity Assessments & Strategy and has over 20 years of experience supporting clients with product and therapeutic area strategy, functional patient journey analysis, opportunity and market assessments, disease area analysis, sales forecasting, and portfolio planning/strategy.​​

Formerly a Vice President in DRG’s infectious disease syndicated research group, Dr. Lebbos led the Infectious Disease research team and has had over 20 years of experience conducting market analysis, opportunity assessments and prioritization and product strategy. ​​

Dr. Lebbos received his medical degree from the University of Massachusetts. Prior to pursuing his medical degree, he attended Tufts University where he graduated summa cum laude in chemical engineering.


arrow_forward
Get in touch with John

Related resources

Multi-product portfolios: addressing complexity through smarter value communication Multi-product portfolios: addressing complexity through smarter value communication
Blog October 9, 2026
Multi-product portfolios: addressing complexity through smarter value communication
Biopharma Commercialization HMO HTA Launch Managed care MCO Payer PBM Pharma pricing
Understanding the impact of drug shortages across markets for API manufacturers Understanding the impact of drug shortages across markets for API manufacturers
Blog October 9, 2026
Understanding the impact of drug shortages across markets for API manufacturers
Biopharma Manufacturing Real-World Data Supply chain
From promise to payment: pricing and reimbursement for combination oncology regimens From promise to payment: pricing and reimbursement for combination oncology regimens
Blog October 9, 2026
From promise to payment: pricing and reimbursement for combination oncology regimens
Biopharma Biotech Bispecific antibodies BsAb Clinical trials Commercialization EMA EMEA Europe HTA Launch Market Access Oncology Payer Pharma Policy pricing
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research